12 Best Rising Penny Stocks To Buy
In this article, we will take a detailed look at the12 Best Rising Penny Stocks To Buy. For a quick overview of such stocks, read our article 5 Best Rising Penny Stocks To Buy. Stocks are roaring aft...
- Supported exchanges /
- NASDAQ /
- CERS.NASDAQ
Cerus Corporation (CERS NASDAQ) stock market data APIs
$1.68
0.05(3.1%)
as of October 22, 2024
Price chart is built with Anychart
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.
Cerus Corporation Financial Data Overview
| 1.63 | |
| 1.68 | |
| - | |
| 1.705 | |
| 1.62 | |
| 1.25-2.585 | |
| 302 M | |
| 185 M | |
| 170 M | |
| -0.03 | |
| 1.182 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'CERS',
Type:
'Common Stock',
Name:
'Cerus Corporation',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG000HBVZX8',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1020214',
EmployerIdNumber:
'68-0262011',
FiscalYearEnd:
'December',
IPODate:
'1997-01-30',
InternationalDomestic:
'Domestic',
Sector:
'Healthcare',
Industry:
'Medical Devices',
HomeCategory:
'Domestic',
IsDelisted:
false,
}
Cerus Corporation Fundamental Data is available in our Financial Data APIs
- Net Revenue 170 M
- EBITDA -12 047 000
- Earnings Per Share -0.13
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Cerus Corporation Earnings via APIs
- Latest Release 2024-08-01
- EPS/Forecast -0.04
Get Cerus Corporation End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Cerus Corporation latest news via APIs
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood got back on track last year. The CEO and stock picker of Ark Invest's aggressive growth exchange-traded funds (ETFs) trounced the market in 2023 after fading awfully in back-to-back years....
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
